Molecular dynamics identifies therapeutic target sites in PLpro, suggesting strategies for ligand discovery and drug repurposing.
The SARS-CoV-2 papain-like protease (PLpro) represents a crucial therapeutic target due to its dual role in viral polyprotein processing and suppression of host immune responses through de-ubiquitination and de-ISGylation activities. To identify novel allosteric druggable sites on PLpro, we developed a molecular dynamics approach with flooding fragments (MDFFr), which extends a previously established method –Molecular Dynamics flooding– enabling broader applicability across biological targets. Using MDFFr, we evaluated interactions of known phenolic inhibitors with SARS-CoV-2 PLpro and identified several biologically significant sites, encompassing allosteric hotspots, cryptic pockets, and regions involved in protein–protein interactions. Our simulations not only confirmed experimentally characterized binding sites, including fragment-binding and protein–protein interaction regions for ubiquitin and ISG15 (Interferon-Stimulated Gene 15), but also uncovered previously unrecognized hotspots for further investigation. These results establish MDFFr as a suitable approach for physics-based druggability assessment of biological targets using only protein 3D structure, while providing detailed insights into fragment-protein interactions at both druggable sites and protein–protein interfaces. These findings also unveil new opportunities for allosteric inhibition of PLpro, potentially advancing therapeutic strategies against SARS-CoV-2 and other coronavirus-related diseases. Furthermore, by using “real” drug-like fragments (rather than standard cosolvent “probes”), MDFFr enhances translational relevance and directly informs drug repurposing and ligand discovery efforts.
No takes yet. Share an insight, caveat, or question.
Pattis et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: